PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 17: Articles 8001-8500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Population education and family planning in the Philippines.
  2. Population growth and family planning in India.
  3. Post-abortion family planning counseling training video for service providers in sub-Saharan Africa: a literature review.
  4. Post-abortion family planning.
  5. Postcoital contraception: present and future options.
  6. Postinor -- the unique method of emergency contraception developed in Hungary.
  7. Postpartum family planning and health needs of women of low income in Istanbul.
  8. Potential health impacts of family planning.
  9. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
  10. Poverty and family planning in Peru. [Pobreza y planificacion familiar en el Peru.]
  11. Power and knowledge in family planning consultations: can a re-analysis of doctor-patient interaction improve client satisfaction?
  12. Pregnancy and lifestyle study: the long-term use of the contraceptive pill and the risk of age-related miscarriage.
  13. Pregnancy, birth control, STDs and AIDS: promoting safer sex. Introduction.
  14. Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication.
  15. The present and future of family planning in Spain. [Presente y futuro de la politica familiar en Espana.]
  16. Primary infertility and oral contraceptive steroid use.
  17. Priorities in the Bangladesh family planning program: 1995-2005.
  18. Problems for discussion on contraception for women after childbirth. [Diskussionnye voprosy kontratseptsii u zhenshchin posle rodov.]
  19. Problems in family planning : a study of Rwandese women's maternal health perceptions. [Problèmes du planning familial : étude des perceptions des femmes rwandaises sur la santé maternelle.]
  20. Proceedings. 2nd Session on Family Planning in the Madrid Community. "Sexuality and reproductive health: on debate". [Cronicas: II Jornadas de Planificacion Familiar en la Comunidad de Madrid: "La sexualidad y salud reproductiva, a debate".]
  21. Procreation or contraception? From bioethics to biopolitics. [Procreation ou contraception? De la bioethique a la biopolitique.]
  22. PROFAMILIA / Nicaragua. Strategy for institutional strengthening: toward a national program for communication in reproductive health / family planning, 1995-1998. [PROFAMILIA / Nicaragua. Estrategia de fortalecimiento institucional: hacia un programa nacional de comunicación en salud reproductiva / planificación familiar, 1995-1998.]
  23. Progestational contraception. [La contraception progestative.]
  24. The progestin-only pills and the levonorgestrel-releasing IUD: two progestin-only contraceptives.
  25. Progress in male contraceptive research.
  26. Project "PRE-VEN": study on postcoital contraception in Spain. [Proyecto "PRE-VEN": estudio sobre anticoncepcion postcoital en Espana.]
  27. Project report on the involvement of Indian Medical Association members for promoting oral contraceptive pill and I.U.C.D. in Gujarat. Training of 1326 family planning counsellors and 83 family planning consultants.
  28. Promotion of family planning and MCH care through dairy co-operatives in rural Bihar, India.
  29. Prospective changes in desired family size and contraceptive use. Main findings and policy implications of the Zimbabwe socio-cultural study.
  30. Prospective study of contraception with levonorgestrel.
  31. Prospects of contraception. [Perspectives de la contraception.]
  32. Protect environment: promote family planning - II.
  33. Protect environment: promote family planning. [I]
  34. Protocols constructed around the nursing process. 2: Oral contraceptives.
  35. Provider rationales for restrictive family planning service practices in Ghana. Final report.
  36. Provider's key role in family planning.
  37. Provider-client communication in family planning clinics in Egypt: styles, predictors and associations with client outcomes.
  38. The provision of family planning services by family doctors in a health board region.
  39. Proximate determinants of fertility and unmet need for family planning in the Arab countries.
  40. Psychosocial factors influencing teenage sexual activity, use of contraception and unplanned pregnancy.
  41. Public funding of family planning leads to moderate reductions in underweight births and infant deaths.
  42. A qualitative study of family planning services at the primary health centre level in the state of Karnataka, India. Final report. Sub-contract No. CI94.110A.
  43. The quality and availability of family planning services and contraceptive use in Tanzania.
  44. Quality of care among Jamaican private physicians offering family planning services.
  45. Quality of care and behavioral aspects in family planning services.
  46. Quality of care at rural health facilities. Family planning. Research summary.
  47. Quality of care in African family planning programs: a survey of findings from situation analysis studies.
  48. Quality of care in family planning service delivery in Kenya: clients' and providers' perspectives.
  49. Quality of care in family planning service delivery in Kenya: clients' and providers' perspectives.
  50. Quality of care in family planning service delivery in Kenya: clients' and providers' perspectives. Final report.
  51. Quality of care in family planning services in Morocco.
  52. Quality of care: an assessment of family planning providers' attitudes and client-provider interactions in Malawi. Executive summary. Draft.
  53. Quality of family planning services from provider's perspective. Observations from a qualitative study in Sitapur district, Uttar Pradesh.
  54. Radio advertising of family planning services in an inner city district. A pilot study.
  55. Re: "Comparison of Recalled and Validated Oral Contraceptive Histories" [letter]
  56. Reasons for commencing and discontinuing contraception with Norplant -- a review of local experience.
  57. Reasons for pregnancy termination: negligence or failure of contraception?
  58. Recent advances on the path to a contraceptive vaccine.
  59. Redefining family planning programs.
  60. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
  61. Reduction of medical barriers to contraception.
  62. Reforming sex: the German movement for birth control and abortion reform, 1920-1950.
  63. The relationship between prenatal care and subsequent modern contraceptive use in Bolivia, Botswana, Egypt, and Thailand.
  64. Relationship between use of condoms and other forms of contraception among human immunodeficiency virus-infected women.
  65. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
  66. Report from the meeting on Safe Delivery and Use of Intra-Uterine Devices (IUDs) and Combined Oral Contraceptives (COCs), October 2-3, 1995.
  67. Report on the Message Development Workshop. Organized by: IEM Unit of the Directorate of Family Planning and The Johns Hopkins University / Center for Communication Programs, October 22-26, 1995, BARD, Comilla, Bangladesh.
  68. Report on the Regional Technical Meeting on Contraceptive Technology / Reproductive Health and Training Approaches Update for Clinical Trainers of Anglophone Africa. Sponsored by: University of North Carolina at Chapel Hill, School of Medicine, Program for International Training in Health [INTRAH], Regional Office, Nairobi.
  69. Reproductive and contraceptive knowledge, contraceptive self-efficacy, and contraceptive behavior among teenage women.
  70. Reproductive health and family planning are human rights. [Salud reproductiva y planificacion familiar son derechos humanos.]
  71. Reproductive health and family planning: a new challenge for the East and South East Asian countries.
  72. Reproductive health conference urges wider use emergency contraception.
  73. Reproductive responsibility and long-acting contraceptives.
  74. Requirements for the quality assurance of hormonal contraceptives.
  75. Research on women's empowerment in Bangladesh: implications for family planning programs. Highlights from the presentation.
  76. Research results relevant for the family planning program. [Istrazivacko iskustvo relevantno za program planiranja porodice.]
  77. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.
  78. Resistance to activated protein C in healthy women taking oral contraceptives.
  79. Resource allocation for family planning in developing countries. Report of a meeting. Committee on Population, Commission on Behavioral and Social Sciences and Education, National Research Council.
  80. Responsibility and irresponsibility: young women and family planning.
  81. Restructuring family planning in the health service: the case of young people's clinics.
  82. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
  83. A review of oral contraceptive use and risk of HIV-transmission.
  84. Review symposium. Three divergent views on The New Politics of Population: Conflict and Consensus in Family Planning, edited by Jason L. Finkle and C. Alison McIntosh, a supplement to Population and Development Review, Vol. 20, 1994. Comment III.
  85. Review symposium. Three divergent views on The New Politics of Population: Conflict and Consensus in Family Planning, edited by Jason L. Finkle and C. Alison McIntosh, a supplement to Population and Development Review, Vol. 20, 1994. Review I.
  86. Review symposium. Three divergent views on The New Politics of Population: Conflict and Consensus in Family Planning, edited by Jason L. Finkle and C. Alison McIntosh, a supplement to Population and Development Review, Vol. 20, 1994. Review II.
  87. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
  88. The risk of venous thromboembolism associated with low oestrogen oral contraceptives.
  89. The role of birth-quota in China's family planning program: how does it limit women's fertility, Hebei, 1980-1988?
  90. The role of family planning programs in contemporary fertility transitions.
  91. Role of opinion leaders in the promotion and delivery of health and family planning services in rural Cameroon. [Role des leaders d'opinion (LO) dans la promotion et la prestation des services de sante et de planification familiale en milieu rural au Cameroun.]
  92. The role of oral contraceptives in the treatment of hyperandrogenic disorders.
  93. The role of scientific research and scientific institute in the family planning program of China.
  94. The role of voluntary surgical contraception (V.S.C.) in family planning programmes [editorial]
  95. RU 486. Contragestion, contraception. [RU 486. Contragestion, contraception.]
  96. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
  97. Safety issues in the provision of injectable contraceptives, Indonesia. Final report.
  98. School's out ... for family planning.
  99. Scientists isolate key sperm protein; finding could lead to birth control drug.
  100. SEATS II clinical protocols for family planning programs: a resource book. Volume I.
  101. Senegal: situation analysis of the family planning service delivery system [Baobab logo]. Condensed report.
  102. Sensitivity to activated protein C; influence of oral contraceptives and sex.
  103. Serum levels of relaxin during the menstrual cycle and oral contraceptive use.
  104. Severe pulmonary thromboembolism in an adolescent due to oral contraceptive use. [Tromboembolismo pulmonar grave secundario ao uso de anticoncepcional em adolescente.]
  105. Sex composition of living children against socio-economic variables while accepting family planning methods.
  106. Sex preference: existence and impact on fertility and family planning in the Sahel.
  107. Sex preferences and family planning: the experience of Israel's immigrant subpopulations in the process of demographic transition.
  108. Sexual behavior of natural family planning users in Germany and its changes over time.
  109. Sexuality is another add-on to already overburdened family planning programs: refuting the myth with operations research findings.
  110. Sexuality, contraception, and the media.
  111. Sexuality, reproduction, and contraception among residents in obstetrics and gynecology.
  112. Should the Association of Physicians of India adopt family planning? [editorial]
  113. Significance of beliefs and values in predicting fertility and contraceptive behaviour in Pakistan.
  114. Similarity between agriculture and family planning.
  115. A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptive.
  116. The situation analysis approach to assessing the supply side of family planning programs.
  117. Situation analysis findings lead to changes in Burkina Faso family planning program.
  118. Situation analysis of family planning service delivery in Senegal.
  119. Situation analysis of the family planning service delivery system in Senegal. Condensed report.
  120. Situation analysis of the family planning service delivery system in Senegal. Final report. [Analyse situationnelle du systeme de prestation de services de planification familiale au Senegal. Rapport final.]
  121. Sixteen-year-old oral contraceptive users in Finland, 1981-1993.
  122. Social and health policy concerns raised by the introduction of the contraceptive Norplant.
  123. Social and situational factors associated with contraceptive switching: implications for practitioners.
  124. Socio-economic determinants of contraceptive use in Sudan.
  125. The socio-psychological factors of family planning with special reference to Iran: a theoretical appraisal.
  126. Socioeconomic development, status of women, family planning and fertility in rural and urban Bangladesh.
  127. SOMARC advertising changes the way contraceptive information is provided to Kazakhstanis.
  128. SOMARC contraceptive marketing program launches in Kazakhstan.
  129. Some lawmakers continue to promote contraceptive use in return for welfare.
  130. South to South Cooperation in Reproductive Health. Emergency contraception should be available to all women. [Press release]
  131. Spousal agreement, women's status and family planning in Nigeria.
  132. Standpoint: perspectives on contraceptive acceptability in the twenty-first century.
  133. Statement on contraception for women with chronic disease. [Declaracion sobre anticoncepcion para mujeres con patologia subyacente.]
  134. Statement on injectable contraception.
  135. Statement on Norplant subdermal contraceptive implant system.
  136. Statement on oral contraceptives and the risk of venous-thromboembolic disease.
  137. Statement on periodic abstinence for family planning.
  138. States using variety of approaches to expand access to family planning under Medicaid. Special analysis.
  139. Statistical compendium on contraceptive prevalence and practice in ECA member states.
  140. Steep increase in contraceptive use in Tanzania.
  141. Sterilisation as a method of contraception: recent trends in Great Britain and their implications.
  142. Sterilization, contraception and abortion: global issues for women.
  143. Still waiting for the contraceptive revolution.
  144. Street theater as a tool to reduce family planning misinformation.
  145. Streptococcal meningitis: a possible complication of prolongued intrauterine contraceptive device (IUD) use. [Meningite a streptocoques: une complication possible du port prolonge d'un dispositif intra-uterin.]
  146. Stress, serotonergic function, and mood in users of oral contraceptives.
  147. The strong commitment. The government of Vietnam has invested nearly 30% of its budget for all the social programs such as education, health, population and family planning.
  148. A study of acceptors and non-acceptors of family planning methods among three tribal communities.
  149. A study of appropriate contraceptive methods after cesarean section.
  150. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
  151. A study of some of the factors relating to contraceptive use in an urban slum.
  152. A study on the effective way and dosage of intravas deferens injection of HFMC for male contraception.
  153. Study report. A study of the cost-effectiveness of the family planning service delivery of the Family Planning Organization of the Philippines.
  154. Subdermal contraceptive implants.
  155. Surveillance of family planning services at Title X clinics and characteristics of women receiving these services, 1991.
  156. A survey of attitude of Kenyan medical doctors on family planning (FP): secondary data analysis.
  157. A survey of knowledge of family planning (FP) methods among Kenyan medical doctors: secondary data analysis.
  158. A survey of Papua New Guinean parturients at the Port Moresby General Hospital: family planning.
  159. Sustainability of family planning programs and organizations: meeting tomorrow's challenges.
  160. Sustainability of family planning programs and organizations: meeting tomorrow's challenges. [Sustentabilidad de los programas y las organizaciones de planificación familiar: respuesta a futuros desafíos.]
  161. A sustainable dissemination model of the ABCs of Basic Family Planning Services. Final report of a dissemination project in the Libertadores-Wari region of Peru. INANDEP / Peru, INOPAL Peru, Contract No. CI94.103A, November 15, 1994 - February 14, 1995. [Un modelo sostenible de divulgacion de "El ABC de la Atencion Basica de Planificacion Familiar". Informe final de un proyecto de divulgacion en la region Libertadores-Wari del Peru.]
  162. Synchronous endometrial and ovarian cancer in young woman taking oral contraception.
  163. Talking with clients about family planning: a guide for health care providers.
  164. Target-setting in family planning programs: controversies and challenges.
  165. Teaching family planning with expert system.
  166. Technical assistance for expanding contraceptive choice in India. Final report.
  167. Teens choose better birth control methods. But condom use is not improved.
  168. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.
  169. Testing alternative approaches to providing integrated treatment of abortion complications and family planning in Kenya: findings from phase I.
  170. Testing alternative approaches to providing integrated treatment of abortion complications and family planning in Kenya: findings from phase I.
  171. TFR dropped to 3.1. The national population and family planning program has strong impact.
  172. Third-generation oral contraceptives: how risky?
  173. Thrombotic risk factors and oral contraception.
  174. Timing of conception and the risk of spontaneous abortion among pregnancies occurring during the use of natural family planning.
  175. Tools from INTRAH calendars for family planning trainers. Reprints of text from past INTRAH calendars, 1987-1994.
  176. Tools to assess family planning counseling: observation and interview.
  177. Towards gender-sensitivity: the Philippine POPCOM experience. How sensitive to gender issues are our family planning personnel?
  178. Tracking the trends. Year-end review of 1995 state actions on reproductive health policy. Family planning services.
  179. Traditional contraception in southern Mozambique: an ethnographic curio or a viable option?
  180. Training community-based distribution agents in family planning: a comprehensive ten-day curriculum.
  181. Transdermal application of steroid hormones for contraception.
  182. Trends and differentials in contraceptive use in rural and urban Bangladesh, 1983-1991.
  183. Trends in contraceptive prevalence, and their determinants.
  184. Trends in fertility, family planning, and childhood mortality in Turkey. Findings from national demographic surveys and population censuses.
  185. The truth about oral contraceptives, heart attack, stroke and blood clots.
  186. Turning point: the inside story of the Papal Birth Control Commission, and how Humanae Vitae changed the life of Patty Crowley and the future of the Church.
  187. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol / 75 micrograms gestodene and 20 micrograms ethinylestradiol / 150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.
  188. Two new surveys of American public and physicians. American women are misinformed about emergency contraceptive option; once explained, many say would be likely to use. OB / GYNs consider "morning-after" pills to be safe and effective; while most have prescribed within last year, only to handful of patients. [Press release]
  189. The U.S. family planning program faces challenges and change.
  190. U.S. support for family planning overseas: the program and the politics.
  191. Ultrasonography: usefulness in localization of the Norplant contraceptive implant system.
  192. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
  193. University students' subjective experiences of oral contraceptive use.
  194. Unmet family planning needs.
  195. Unmet need and demand for family planning in selected rural areas in Vietnam.
  196. Unmet need and demand for family planning in Tanzania.
  197. The unmet need and demand for modern contraception in the Philippines.
  198. Unmet need for family planning in Jamaica.
  199. Unmet need for family planning: challenges for the future.
  200. Unmet need in Egypt, Morocco and Jordan: what do we really know about reasons for non-use of contraception?
  201. Unmet need in family planning in South Asia region.
  202. Update on contraception 2: post-coital and barrier methods.
  203. Upgrading family planning services. Responses to ICPD.
  204. The Urban MCH-FP Initiative: a partnership for urban health and family planning in Bangladesh. An assessment of programme needs in zone 3 of Dhaka city.
  205. USAID and Turkey -- a model partnership in population and family planning. [Nufus ve aile planlamasinda ornek bir isbirligi.]
  206. USAID's population and family planning assistance in Turkey. Annual report -- 1995.
  207. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.
  208. Use of long-acting contraceptives [letter]
  209. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
  210. Use of post-coital contraception in Finland is increasing.
  211. Use of Private Practitioners for Promoting Oral Contraceptive Pills in Gujarat. Sponsored by: the Population Council, India.
  212. Use of subdermal contraceptive implants in a community-based family planning program. Experience after two years.
  213. Use of the pill by adolescents for contraception or as therapy. [Pilgebruik door adolescenten voor anticonceptie of als therapie.]
  214. User and tolerance profile of the principal contraceptive methods used in primary care: hormonal contraceptives, intrauterine devices [IUDs] and the diaphragm. [Perfil de usuaria y tolerancia de los principales metodos anticonceptivos en atencion primaria: anticonceptivos hormonales (ACH), dispositivo intrauterino (DIU) y diafragma.]
  215. Using an ovarian monitor as an adjunct to natural family planning.
  216. Using induced abortion to measure contraceptive efficacy.
  217. Vaccination for birth control.

     

  218. Vaginal and intrauterine contraception. [Contraception vaginale et intra-uterine.]
  219. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills) -- an Indian experience. An ICMR task force study.
  220. Vaginal foaming tablet use: experience in Family Planning Association of Kenya.
  221. Vaginal rings for contraception.
  222. Validation of measures of condom and other contraceptive use among women at high risk for HIV infection and unintended pregnancy.
  223. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  224. Viet Nam's population and family planning programme: the role of IEC. A GTZ-supported project.
  225. Vision 2000. Sexual and reproductive health. Family planning puts promises into practice.
  226. What is the problem with emergency contraception?
  227. What makes a contraceptive acceptable?
  228. When is "emergency" contraception the right name for postcoital treatment?
  229. When is it safe to switch from oral contraceptives to hormonal replacement therapy?
  230. When to begin postpartum methods. Contraceptive update.
  231. Who holds up half of heaven? Male involvement in family planning. Responses to ICPD.
  232. Why the Vatican is so against family planning and immigration control.
  233. Why women who don't want to get pregnant don't use contraception.
  234. Winning through. Stories from family planning associations that are fighting hard to overcome obstacles or reach isolated groups.
  235. Woman's natal family and adoption of family planning.
  236. Women in need of family planning services.
  237. Women's "tontines" in Yaounde, Cameroon: using social networks for family planning communication: results of focus group discussion research, December 1993.
  238. Women's experience of family planning in two rural communes in Vietnam.
  239. Women's experience of family planning in Vietnam.
  240. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
  241. Women's knowledge of the contraceptive pill: the results of a focus group.
  242. Women's perceptions of female contraceptive behavior: experimental evidence of the sexual double standard.
  243. Women's socioeconomic position and contraceptive behavior in Togo.
  244. Women's status and family planning in Bangladesh: an analysis of focus group data. Final report. Subcontract Number CI92.60A.
  245. Women, contraception and STDs including HIV. Editorial review.
  246. Women, sexuality, and AIDS: new issues for family planning programs.
  247. World population growth, family planning, and American foreign policy.
  248. Wujiang's service-oriented family planning programme.
  249. Youth for Youth Foundation. Romanian Family Planning Project.
  250. Youth: influence of religion on contraceptive use. [Juventud: influencia de la religion en el uso de anticonceptivos.]
  251. In Zimbabwe, quality services increase contraceptive prevalence, but effect of education is inconsistent.
  252. The Lactational Amenorrhea Method (LAM): a postpartum introductory family planning method with policy and program implications.
  253. Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive; final three-year report.
  254. Repeat abortion and contraceptive use. Report from an interview study in Stockholm.
  255. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
  256. Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and influence of hormonal contraceptives.
  257. Are low-dose oral contraceptives safer and better?
  258. The availability and accessibility of the contraceptive implant from family planning agencies in the United States, 1991-1992.
  259. Billings natural family planning in Shanghai, China.
  260. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer.
  261. Clinical and metabolic features of desogestrel: a new oral contraceptive preparation.
  262. Clinical comparison of monophasic oral contraceptive preparations of gestodene / ethinyl estradiol and desogestrel / ethinyl estradiol.
  263. Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents.
  264. Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics.
  265. Comparison of adolescent and adult experiences with Norplant levonorgestrel contraceptive implants.
  266. Contraception with Norplant implants.
  267. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.
  268. Contraceptive application of the Bioself fertility indicator.
  269. Contraceptive efficacy of the Copper T 380A and Copper T 200 intrauterine devices: results from a comparative clinical trial in six developing countries.
  270. Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries.
  271. Contraceptive implant users and their access to removal services in Bangladesh.
  272. Contraceptive outcomes among post-partum and post-abortal adolescents.
  273. Contraceptive use and attitudes in Great Britain.
  274. Contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol.
  275. Copper intrauterine contraceptive device and pregnancy rate.
  276. Detection of Chlamydia trachomatis in asymptomatic women: relationship to history, contraception, and cervicitis.
  277. Dose-finding study of a contraceptive ring releasing norethindrone acetate / ethinyl estradiol.
  278. The dynamics of oral contraceptive use in the Netherlands 1990-1993.
  279. The effect of husband counseling on Norplant contraceptive acceptability in Bangladesh.
  280. Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus.
  281. The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne.
  282. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
  283. Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.
  284. Emergency contraception alters progesterone-associated endometrial protein in serum and uterine luminal fluid.
  285. An epidemiological study on the relationship of ectopic pregnancy and the use of contraceptives in Beijing -- the incidence of ectopic pregnancy in the Beijing area.
  286. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
  287. Family planning in Nairobi: a situation analysis of the City Commission clinics.
  288. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study.
  289. Increased risk of inflammatory bowel disease associated with oral contraceptive use.
  290. The influence of endogenous and exogenous sex hormones in adolescents with attention to oral contraceptives and anabolic steroids.
  291. The integration of family planning and childhood immunization services in Togo.
  292. Long-acting injectable contraception with depot medroxyprogesterone acetate.
  293. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
  294. Male contraception: hormonal, mechanical and other.
  295. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
  296. The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
  297. Noncontraceptive effects of hormonal contraceptives: bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility.
  298. Obstacles to use of hormonal contraception.
  299. Oral contraceptives and risk of breast cancer in women aged 20-54 years.
  300. Parity, contraception, infertility, and the risk of epithelial ovarian cancer.
  301. Progestogen-only contraceptives during lactation: I. Infant growth.
  302. Progestogen-only contraceptives during lactation: II. Infant development.
  303. Risk of cervical dysplasia in users of oral contraceptives, intrauterine devices or depot-medroxyprogesterone acetate.
  304. The role of hormonal contraception in adolescents.
  305. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
  306. Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives.
  307. Sexual activity, contraception, and reproductive factors in predicting endometriosis.
  308. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus.
  309. SMART START: an option for adolescents to delay the pelvic examination and blood work in family planning clinics.
  310. Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
  311. A test of alternative supervision strategies for family planning services in Guatemala.
  312. Tissue specificity of the acrosomal protein SP-10: a contraceptive vaccine candidate molecule.
  313. Trial of a new method of natural family planning in Liberia.
  314. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk.
  315. Issues to consider in the production of hormonal contraceptives.
  316. Management of community-based family planning programmes. Manual for trainers.
  317. Pest management for warehouses storing contraceptive products in developing countries.
  318. Constraints on supply and demand for family planning: evidence from rural Bangladesh.
  319. Norplant -- a long acting contraceptive implant: a critical review.
  320. Family planning programme effort in South Asia.
  321. Contraceptive transition in Asia.
  322. Handbook of indicators for family planning program evaluation.
  323. Inreach: reaching potential family planning clients within health institutions.
  324. Integrating STDs and AIDS services into family planning programs. Training community workers.
  325. Increasing community participation in family planning programs. [Accroître la participation de la communauté aux programmes; Mayor participación comunitaria en los programas de planificación familiar.]
  326. Family planning lessons and challenges: making programs work./Lecciones y retos de la planificacion familiar: para que un programa tenga exito./Legons et defis du planning familial: comment faire marcher les programmes.
  327. Catholic beliefs about contraception [letter]
  328. Confidentiality, contraception, and young people [letter]
  329. Confidentiality, contraception, and young people [letter]
  330. Deregulating emergency contraception. Family planning nurses have useful skills [letter]
  331. Deregulating emergency contraception. The alternative may be unwanted pregnancies [letter]
  332. Family planning and AIDS prevention can be combined [letter]
  333. Funding family planning [letter]
  334. Funding family planning [letter]
  335. Funding international family planning [letter]
  336. Long acting methods of contraception [letter]
  337. Long acting methods of contraception [letter]
  338. Long acting methods of contraception. Much to offer.
  339. Promotion of family planning services in practice leaflets.
  340. Interactions between economic reform and family planning policies in rural China.
  341. Interactions of oral contraceptives and other drugs. [Wie sich orale Kontrazeptiva und Medikamente in ihrer Wirkung beeinflussen.]
  342. Interest in natural family planning among female family practice patients.
  343. International Planned Parenthood Federation Journalists' Briefing on the International Conference on Population and Development, 3 and 4 September, 1994. Abortion; adolescents; reproductive health: some controversial issues. Notes.
  344. International Planned Parenthood Federation. Western Hemisphere Region, Inc.
  345. Interpersonal communication in family planning in Pakistan.
  346. An interpersonal communication network model of media effects in family planning adoption. Draft.
  347. Intrauterine contraceptives, 1972-1993.
  348. Introducing the contraceptive implant in Thailand: impact on method use and costs.
  349. The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia.
  350. The introduction of new methods of contraception: ethical perspectives.
  351. Introduction. "Preventing Unintended Pregnancy: The Role of Hormonal Contraceptives.
  352. Introduction: implications of reproductive health for the design of family planning services.
  353. Invisible man: can global efforts raise a new generation of men who take family planning seriously?
  354. Involving men in family planning: Kenya and Baltimore.
  355. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
  356. Is oral contraception safe? [Je peroralni antikoncepce bezpecna?]
  357. Islam and family planning and the role of Muslim doctors.
  358. Islam's attitude towards family planning.
  359. Issues of gender and equity in family planning: 1994 and beyond.
  360. The Kaiser Survey on Public Knowledge and Attitudes on Contraception and Unplanned Pregnancy: abortion rates.
  361. The Kaiser Survey on Public Knowledge and Attitudes on Contraception and Unplanned Pregnancy: contraceptive use and decision making: the role of men.
  362. The Kaiser Survey on Public Knowledge and Attitudes on Contraception and Unplanned Pregnancy: emergency contraceptive pills.
  363. The Kaiser Survey on Public Knowledge and Attitudes on Contraception and Unplanned Pregnancy: teen sexuality and teen pregnancy.
  364. Knowledge of contraception in abortion seekers compared with other pregnant and non-pregnant women.
  365. Knowledge of sexually transmitted diseases, HIV infection and AIDS among sexually active adolescents in Nairobi, Kenya and its relationship to their sexual behaviour and contraception.
  366. Knowledge of, attitude towards and practices of family planning, family welfare issues among male wage workers in Tanzania. A preliminary baseline survey report for the Male Motivation and Education Project (URT/94/P02)
  367. Labeling emergency contraception.
  368. Lansoprazole does not affect the bioavailability of oral contraceptives.
  369. Launching a second contraceptive technology revolution.
  370. Lea's Shield, a new barrier contraceptive preliminary clinical evaluations three-day tolerance study.
  371. Lessons learned on door-step delivery of injectable contraceptives.
  372. Lessons learned on doorstep delivery of injectable contraceptives. Workshop proceedings, September 28, 1994, Sasakawa International Training Centre Auditorium, International Centre for Diarrhoeal Disease Research, Bangladesh.
  373. Methods for costing family planning services.
  374. Methods of contraception and rates of genital infections.
  375. Methods of estimating contraceptive prevalence rates for small areas: applications in the Dominican Republic and Kenya.
  376. Methods of estimating contraceptive prevalence rates for small areas: applications to the Dominican Republic and Kenya.
  377. Mexico: on family planning.
  378. Midterm review of the Tanzania Family Planning Services Support (FPSS) Project (621-0173)
  379. Mifepristone (RU486) and emergency contraception. Unavailability of mifepristone represents a neglect of Australian women's health.
  380. Mifepristone in practice. Running an early medical abortion service. Proceedings of a conference organised by the Birth Control Trust on 22 April 1993 at the Royal Society of Medicine, London.
  381. Migraine and combined oral contraceptives. Joint statement.
  382. Minister Peng on population situation and major experiences of family planning implementation.
  383. Minister Peng reports on the population status and family planning programme in 1993.
  384. Misinformation, mistrust, and mistreatment: family planning among Bolivian market women.
  385. Misperceptions about contraceptives keep abortion incidence high in Ghana.
  386. Mobilization of resources for a second contraceptive technology revolution.
  387. Models of women-centred reproductive health services. Family planning and reproductive health services in Profamilia - Colombia.
  388. Modern barrier methods: effective contraception and disease prevention.
  389. Modulatory influence of oral contraceptives on mammary growth pattern of normal and ovariectomised mice.
  390. Monitoring and evaluation of the quality of family planning services. [Monitoreo y evaluacion de la calidad de los servicios de planificacion familiar.]
  391. Monthly combined injectable contraceptives and neoplasia.

     

  392. Monthly injectable contraceptives: are they a valuable addition to the birth control cafeteria? [abstract]
  393. More evidence for the public health value of family planning [editorial]
  394. More funds urged for contraceptive research.
  395. Most British women use reliable contraceptive methods, but many fear health risks from use.
  396. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
  397. Multicenter study in Hungary with a 30 micrograms ethinylestradiol- and 150 micrograms desogestrel-containing monophasic oral contraceptive.
  398. Multistate survival models for transitions and reverse transitions: an application to contraceptive use data.
  399. National Campaign Project on Family Planning II, PL 480, MEF-AID-APROPO. First revision. Los Tromes II. [Proyecto Campana Nacional en Planificacion Familiar II, PL 480 MEF-AID-APROPO. Revision I. Las Tromes II.]
  400. A national decrease in birth rates in Egypt, and an increase in contraceptives use.
  401. National Family Health Survey (MCH and Family Planning), India, 1992-93. Introductory report.
  402. National Family Health Survey (MCH and family planning), Maharashtra, 1992-93.
  403. National Family Health Survey (MCH and family planning), Maharashtra, 1992-93. Summary report.
  404. National Family Health Survey (MCH and Family Planning), Tamil Nadu, 1992.
  405. National Family Health Survey (MCH and Family Planning), Tamil Nadu, 1992: summary report.
  406. National Family Health Survey (MCH and Family Planning), Uttar Pradesh, 1992-93.
  407. Recent trends in contraceptive use.
  408. Recommendations for updating selected practices in contraceptive use: results of a technical meeting. Volume I: combined oral contraceptives, progestin-only injectables, Norplant implants, copper-bearing intrauterine devices.
  409. Recommendations for updating selected practices in contraceptive use: results of a technical meeting. Volume I: Combined oral contraceptives, progestin-only injectables, Norplant implants, copper-bearing intrauterine devices.
  410. Reduced number of abortions. Result of easily accessible and good quality contraception counseling and inexpensive oral contraceptives. [Sankta aborttal. Lattillganglig och kvalitativ preventivmedelsradgivning och billiga p-piller ger resultat.]
  411. Reflections on African-American resistance to population policies and birth control.
  412. Regional variations in contraceptive choice in Andhra Pradesh.
  413. Regulations of the province of Shaanxi concerning family planning.
  414. Relation of pulmonary lymphangioleiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.
  415. Relationship between AIDS and family planning programmes: a rationale for developing integrated reproductive health services.
  416. Relationship between contraceptive method choice and beliefs about HIV and pregnancy prevention.
  417. The relationship between female adolescents' oral contraceptive adherence and autonomy.
  418. Relative self-efficacy of contraception among male and female adolescents: validation of the French version of the Levinson scale. [L'auto-efficacite relative a la contraception chez les adolescentes et les adolescents: la validation de la version francaise de l'echelle de mesure de Levinson.]
  419. Remarks of the family planning program manager.
  420. Remarks of the family planning program manager.
  421. Remarks of the family planning program manager.
  422. Removing legal and policy barriers affecting delivery of family planning services in the Africa Region. Research framework for use by local researchers.
  423. Report of a meeting on improving access to quality care in family planning. Medical eligibility criteria for initiating use of selected methods of contraception: combined oral contraceptives, progestogen-only pills, DMPA, Norplant implants and copper IUDs.
  424. Report of focus group discussions to identify potential designs for a national family planning logo. National Family Planning Logo Development Workshop, Naivasha, Kenya, September 27 - 30, 1994.
  425. Report on the Survey of Family Planning Knowledge, Attitude and Practice in Hong Kong 1992.
  426. Report: workshops on research methods in reproductive health and family planning in Bangladesh.
  427. Reproductive function and contraception in the postpartum period.
  428. Reproductive health and family planning. Maternal mortality a matter of resource allocation.
  429. Reproductive health approach to family planning. Presentations from a panel held on Professional Development Day, at the USAID Cooperating Agencies meeting, February 25, 1994, Washington, DC.
  430. A reproductive health approach to the objectives and assessment of family planning programs.
  431. Reproductive health, reproductive rights, morbidity, mortality and family planning: the challenge of the new frontier.
  432. Reproductive medicine and family planning -- 2018.
  433. Reproductive rights and family planning national policies and program of action.
  434. Reproductive rights, family planning: a cornerstone of control.
  435. Republic of Uganda. Family planning and maternal health: skills curriculum for nurse aides. Volume 1: Content outline.
  436. Republic of Uganda. Family planning and maternal health: skills curriculum for nurse aides. Volume 3: Trainer's and and trainee's materials.
  437. Response to Women's Global Network for Reproductive Rights' call for an end to research and development of antifertility or contraceptive vaccines (letter)
  438. Results of a case-control study of the current effect of various factors of cervical cancer risk. 2. Contraceptive behavior and the smoking factor. [Ergebnisse einer Fall-Kontroll-Studie zum aktuellen Einfluss verschiedener Faktoren auf das Zervixkarzinomrisiko. 2. Mitteilung: Kontrazeptionsverhalten und Faktor Rauchen.]
  439. Results of the pre-test on the national family planning emblem. [Resultats du pre-test sur le depliant de l'embleme national de PF.]
  440. Rethinking family planning policy in light of reproductive health research.
  441. 1993 Contraceptive Prevalence Survey, Jamaica. Volume II: Knowledge and attitudes towards family, contraception and AIDS.
  442. 1993 contraceptive social marketing statistics.
  443. 1994 Planned Parenthood service report.
  444. 20 questions about International Planned Parenthood Federation, Western Hemisphere Region.
  445. A 5-year evaluation of Norplant contraceptive implants in China.
  446. The ABC of family planning. Promoting a better quality of life.
  447. Abortion and contraception in Kazakhstan, Kyrgyzstan, and Uzbekistan: the provider prospectives (preliminary results)
  448. Abortion and sterilization better covered than contraception by the majority of insurance plans.
  449. About contraceptive history. ["Von Prasern, Pillen, Pasten."]
  450. About the 1993 federal meeting on family planning centers. [Jahrestagung 1993 der Familienplanungszentren.]
  451. Acceptability of Norplant contraceptive subdermal implants in Kenya.
  452. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
  453. Acceptance of family planning and linkages with development variables: evidence from an 80-village study in Orissa.
  454. Access to family planning for all for $3 a year, says UN.
  455. Access to family planning services and health insurance among low-income women in Arizona.
  456. Access, quality of care, and medical barriers in international family planning programs.
  457. Accessories after all? Contraception, sex education, and counseling in the implementation of the law on pregnancy and family assistance. [Doch nur Beiwerk? Verhutung, Sexualpadagogik und Beratung in der Umsetzung des SFHG.]
  458. Adaptation of the Indonesian family planning program to the socio-cultural context.
  459. Address by Dr. Haryono Suyono, State Minister for Population / Chairman, National Family Planning Coordinating Board, Republic of Indonesia, to the meeting of the Population Association of America, May 5, 1994.
  460. Adolescence and contraception (letter) [Adolescencia y anticoncepcion.]
  461. Adolescent contraceptive counseling and gynecology: a deficiency in pediatric office-based care.
  462. Adolescent contraceptive use and communication: changes over a decade.
  463. Adolescent contraceptive use: toward a more integrated model.
  464. Adolescents' knowledge of how to use contraceptives.
  465. The advance of the contraceptive revolution.
  466. Advances in contraceptive vaccine research.
  467. Advances in hormonal contraception. [Avances en la contracepcion hormonal.]
  468. Advances in hormonal contraception. A new micro-pill with especially low hormone effect. [Fortschritt in der hormonalen Kontrazeption. Eine neue Mikropille mit besonders niedriger Gesamthormonwirkung.]
  469. Advances in outpatient female surgical contraception. [Avances en anticoncepcion quirurgica femenina ambulatoria.]
  470. Agricultural approach on family planning: means to promote community health. A case from Glintang village, Sambi subdistrict, Boyolali regency.
  471. Aid agencies urged -- more family planning.
  472. AIDS prevention and family planning services. [Prevencion del SIDA y servicios de planificacion familiar.]
  473. AIDS prevention. Guidelines for maternal-child health and family planning program (MCH / FP) administrators. II. AIDS and maternal-child health. [Prevencion del SIDA: normas para los administradores de los programas de salud maternoinfantil y de planificacion familiar (SMI / PF). II. El SIDA y la salud maternoinfantil.]
  474. Alaska / Russian Far East women's health and family planning.
  475. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center.
  476. Analysis of longitudinal data on contraceptive use.
  477. An analysis of the regulation processes governing contraceptive methods in Bolivia. Final report. The Population Council / Bolivia in-house project, October 1993 - February 1994. [Analisis del proceso regulatorio para metodos anticonceptivos en Bolivia.]
  478. Ancient birth control [letter]
  479. Ancient birth control [letter]
  480. Ancient birth control [letter]
  481. Ancient birth control [letter]
  482. In ancient times, flowers and fennel for family planning.
  483. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
  484. Anti-contraceptive campaign. Niger / Burkina Faso / Mali.
  485. Anti-fertility vaccines: current status and implications for family planning programmes.
  486. The antinidatory activity of oral contraceptives. [L'activite antinidatoire des contraceptifs oraux.]
  487. Antiprogestins in contraception. [Antiprogestinas en anticoncepcion.]
  488. An appraisal of the demand for family planning in Bihar.
  489. Arab NGOs declare that abortion is not accepted as a family planning method, and that they will refuse any thing that contradicts their beliefs.
  490. Aspects of failed family planning in the United States of America and Germany.
  491. Assessing the impact of the quality of family planning services on contraceptive use in Peru: a case study linking situation analysis data to the DHS.
  492. An assessment of DOH training courses for family planning providers in the Cordillera Administrative Region.
  493. Association for Voluntary Surgical Contraception: a technical statement on quinacrine pellets for nonsurgical female sterilization.
  494. At what "infant-age" can levonorgestrel contraceptives be recommended to nursing mothers?
  495. At what age should oral contraception be stopped? [A quel age faut-il arreter la contraception orale?]
  496. The attitude of women in Cameroon toward family planning: unmet needs and future intentions concerning use of family planning. [Attitude de la femme camerounaise vis-a-vis de la planification familiale: les besoins non-satisfaits et l'intention d'utiliser la planification familiale.]
  497. Attitude toward contraception among 16-20-year-olds. [Holdning til praevention blandt 16-20-arige.]
  498. The attitudes of clinic staff as factors in women's selection of Norplant implants for their contraception.
  499. Attitudes of males to contraception in a Kenyan rural population.
  500. Attitudes toward childbearing and changes in sexual and contraceptive practices among HIV-infected women.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info